1Hirawat S, Budman D R, Kreis W. The androgen receptor: structure, mutations, and antiandrogens[J]. Cancer Invest, 2003, 21(3): 400-417.
2Feldman B J, Feldman D. The development of androgen-independent prostate cancer[J]. Nat Rev Cancer, 2001, 1(1): 34-45.
3Navarro D, Luzardo O P, Fernandez L, et al. Transition to androgen-independence in prostate cancer[J]. J Steroid Biochem Mol Biol, 2002, 81(3): 191-201.
4Edwards J, Krishna N S, Grigor K M, et al. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer[J]. Br J Cancer, 2003, 89(3): 552-556.
5Suzuki H, Ueda T, Ichikawa T, et al. Androgen receptor involvement in the progression of prostate cancer[J]. Endocr Relat Cancer, 2003, 10(2): 209-216.
6Koivisto P, Kononen J, Palmberg C, et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer[J]. Cancer Res, 1997, 57(2): 314-319.
7Palmberg C, Koivisto P, Kakkola L, et al. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer[J]. J Urol, 2000, 164(6): 1992-1995.
8Culig Z, Klocker H, Bartsch G, et al. Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy[J]. Am J Pharmacogenomics, 2001, 1(4): 241-249.
9Taplin M E, Rajeshkumar B, Halabi S, et al. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663[J]. J Clin Oncol, 2003, 21(14): 2673-2678.
10Taplin M E, Bubley G J, Shuster T D, et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer[J]. N Engl J Med, 1995, 332(21): 1393-1398.
